In cancer, sustained STAT3 activation occurs through several mechanisms, such as cytokine stimulation, mutated cytokine receptors, mutated kinases (such as JAK family kinases), activation of non-receptor kinases (such as Src family kinases) or loss of negative regulators (such as SOCS and PIAS proteins) [5]. The gene discussed is STAT3; the disease is cancer.